德国炎症性肠病或自身免疫性肝炎儿童及青少年的疫苗接种率与免疫力
在德国7个中心评估329名炎症性肠病(n=300)或自身免疫性肝炎(n=29)儿童及青少年的疫苗接种率与免疫力,86%接受长期免疫抑制。六价疫苗和麻腮风疫苗接种覆盖率良好,但2005年前出生者水痘-带状疱疹病毒(VZV)疫苗接种不足,且接种证书和水痘病史均不能可靠预测VZV免疫力,提示需血清学检查并在开始免疫抑制治疗前接种。
要点
- 86%的患儿接受长期免疫抑制,六价疫苗4剂接种率89%,麻腮风疫苗至少1剂99%、2剂92%。
- 2005年及以后出生者VZV疫苗接种率88%,2005年前出生者补种率仅25%。
- 118名有VZV接种记录者中25人(21%)抗VZV IgG不足,接种证书不能可靠预测免疫力。
核心结论
- 本队列中六价疫苗和麻腮风疫苗覆盖率良好,但2005年前出生患者VZV疫苗接种不足。
- 接种证书和水痘病史均不能可靠预测VZV免疫力,提示需血清学检查并在开始免疫抑制治疗前接种。
研究设计与样本
- 在德国7个中心评估329名炎症性肠病(n=300)或自身免疫性肝炎(n=29)儿童及青少年的疫苗接种率与免疫力。
- 通过接种证书、水痘病史及检测抗VZV和抗麻疹IgG抗体进行评估。
主要发现
- 全队列86%接受长期免疫抑制治疗。
- 89%有4剂六价疫苗接种记录,325人(99%)至少1剂麻腮风疫苗接种记录,300人(92%)有2剂记录。
- 已免疫患者中11%抗麻疹IgG浓度不足。
- 2005年及以后出生者VZV疫苗接种率88%,2005年前出生者补种率仅25%(n=67)。
- 118名有VZV接种记录者中25人(21%)抗VZV IgG不足;198名有水痘病史者中6人抗VZV IgG检测不到;29名既无水痘病史也无VZV接种者中20人抗VZV IgG充足。
临床怎么用
- 作者认为接种证书和水痘病史均不能可靠预测VZV免疫力,提示需进行血清学检查,并在开始免疫抑制治疗前根据需要接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Immunosuppressed patients are at risk of severe infections with vaccination preventable diseases. We evaluated vaccination rate and immunity of children and adolescents with inflammatory bowel disease (IBD) and autoimmune hepatitis (AIH). METHODS: Immunization rate of 329 children with IBD (n = 300) and AIH (n = 29) was assessed in seven German centres using vaccination certificates, history of chicken pox and by determining anti-varicella zoster virus (VZV) and anti-measles IgG antibodies. RESULTS: Of the total cohort 86% received long-term immunosuppression. Four doses of a hexavalent vaccine were documented in 89%, at least one dose of measles, mumps, and rubella (MMR) vaccination was documented in 325 (99%), with 300 (92%) receiving two doses. Anti-measles IgG concentrations were insufficient in 11% of the immunized patients. VZV vaccination was officially recommended in Germany since 2004, and implemented in 88% born from 2005 onwards. In patients born earlier VZV catch up vaccination only reached 25% (n = 67). Of 118 patients with documented VZV vaccination 25 (21%) did not display sufficient anti-VZV IgG. Of 198 patients with a history of chicken pox, six had undetectable anti-VZV IgG. Of 29 patients having neither had chicken pox nor VZV vaccination, 20 were found to have sufficient anti-VZV IgG. CONCLUSIONS: In our cohort vaccination coverage for hexavalent and MMR vaccinations was good, but insufficient for VZV vaccination in patients born before 2005. Neither the vaccination certificate nor the history of chicken pox is reliable to predict VZV immunity indicating a need for serologic investigations and if needed vaccination before initiating immunosuppressive therapy.
引用
- Cagol L, Seitel T, Ehrenberg S, et al. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine. 2019. PMID: 31879123. doi:10.1016/j.vaccine.2019.12.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。